Scientific Computing World is hosting a virtual roundtable in February for research leaders, scientists and R&D experts in drug discovery, particularly those working with new modalities, such as RNA ...

The pharmaceutical landscape is undergoing a dramatic transformation. New modalities are reshaping what's possible in drug development, from monoclonal antibodies to RNA therapies, from small ...

Amazon Braket users can employ Nvidia's open-source quantum development platform to develop hybrid workflows using the CUDA-Q ...

Intelligent Omics' Dr Rob Grundy discusses how combining AI with big data can lead to better drug discovery processes and that partnerships can help more organisations leverage cutting-edge tools.

Amazon Braket users can employ Nvidia's open-source quantum development platform to develop hybrid workflows using the CUDA-Q ...

Action Summit in Paris, Commission President Ursula von der Leyen has launched InvestAI, an initiative to mobilise €200 billion for investment in AI, including a new European fund of €20 billion for ...

Oxford Economics released a quantum economic report stating quantum computing could add £200 billion to the UK economy by 2045, but highlighted the risks that without funding the UK will lose both its ...

Deep Genomics, a company specialising in AI therapeutics, has announced that its artificial intelligence-based drug discovery platform has identified a novel treatment target and corresponding drug ...

The two companies are working to integrate LightSolver’s technology with Ansys LS-DYNA nonlinear dynamics structural simulation software to accelerate simulations for automotive and aerospace ...

The benefits of building a good working relationship between a LIMS supplier and a contract research organisation (CRO) can’t be underestimated, notes Richard Stember, founder and CEO of LABTrack, ...

Standardising analytical data is the key to unlocking AI-driven innovation in chemical and pharmaceutical research. Richard Lee, Director, Core Technology and Capabilities at ACD/Labs explores how ...

Tim Doggett is the CEO of the Chemical Business Association where he advocates for the sector in the UK and across the world. Doggett: My background is in supply chain logistics. I've worked in the UK ...